ACTIVE

TRIMEPHAR

Export PDF

Financial year 2025 · closed on 31/12/2025

Net result

166,9 k €

-13.2% YoY

Gross margin

528,6 k €

-5.2% YoY

Equity

777,3 k €

-0.4% YoY

Workforce

3,6 ETP

-14.3% YoY

What does TRIMEPHAR do?

TRIMEPHAR is a Private limited company incorporated in 2008. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Faimes. It employs on average 3,6 ETP workers (FTE).

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0807.210.244

Incorporation

20/10/2008

Legal form

Private limited company

Registered office

Rue de la Champignotte(AIN) 13
4317 Faimes · WallonieSee on map

Contributed capital

100 000,00 €

Latest accounts

31/12/2025

Average workforce

3,6 ETP

Activities (NACE)

47730Dispensing chemist in specialised stores· main 47730Dispensing chemist in specialised stores 47740Retail sale of medical and orthopaedic goods in specialised stores 47741Retail sale of medical and orthopaedic goods in specialised stores 47750Retail sale of cosmetic and toilet articles in specialised stores 47750Retail sale of cosmetic and toilet articles in specialised stores

Signals

ProfitableSolid equityLow riskPositive cashflowPositive EBITDAHealthy social debts

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 17 financial years

	2025		2024		2023		2022		2021		2020		2019		2018		2017		2016		2015		2014		2013		2012		2011		2010		2009
Income statement
Gross margin	528,6 k €	-5.2%	557,5 k €	-0.1%	557,9 k €	-0.1%	558,7 k €	+9.8%	508,7 k €	+11.9%	454,6 k €	+22.5%	371,1 k €	-7.5%	401,1 k €	-1.1%	405,4 k €	+18.6%	341,8 k €	-13.9%	397,1 k €	+23.3%	322 k €	+1.4%	317,5 k €	-3.1%	327,6 k €	+8.1%	303,1 k €	+6.8%	283,9 k €	+23.6%	229,6 k €
EBITDA	290,6 k €	-10.7%	325,3 k €	+2.1%	318,7 k €	-5.0%	335,6 k €	+4.2%	322 k €	+8.7%	296,3 k €	+6.1%	279,2 k €	-13.7%	323,6 k €	+0.3%	322,7 k €	+25.7%	256,7 k €	-15.1%	302,4 k €	+28.2%	235,9 k €	+1.8%	231,6 k €	-5.2%	244,3 k €	+10.4%	221,3 k €	+10.2%	200,9 k €	+54.2%	130,3 k €
Operating result	225,2 k €	-13.2%	259,5 k €	+4.2%	249 k €	-6.1%	265,1 k €	+5.5%	251,1 k €	+0.3%	250,4 k €	+9.7%	228,3 k €	-3.7%	237 k €	-0.8%	238,8 k €	+37.6%	173,6 k €	+22.5%	141,7 k €	+66.9%	84,9 k €	+4.6%	81,2 k €	-14.5%	94,9 k €	+49.3%	63,6 k €	+41.0%	45,1 k €	+1572%	-3,1 k €
Net result	166,9 k €	-13.2%	192,1 k €	+4.7%	183,6 k €	-4.1%	191,4 k €	+10.9%	172,6 k €	+1.6%	169,8 k €	-13.0%	195,3 k €	-2.1%	199,5 k €	+22.6%	162,7 k €	+33.9%	121,5 k €	+8.9%	111,5 k €	+52.1%	73,3 k €	+18.5%	61,9 k €	-4.4%	64,7 k €	+205%	21,2 k €	+29.0%	16,5 k €	-18.6%	20,2 k €
Balance sheet
Equity	777,3 k €	-0.4%	780,5 k €	+1.6%	768,4 k €	+0.5%	764,8 k €	+1.5%	753,3 k €	-9.3%	830,8 k €	-21.7%	1,1 M €	+22.6%	865,7 k €	+29.9%	666,2 k €	+32.3%	503,5 k €	+31.8%	382 k €	+28.3%	297,8 k €	+32.7%	224,5 k €	+0.8%	222,6 k €	+41.0%	157,9 k €	+15.5%	136,7 k €	+13.7%	120,2 k €
Total assets	1,3 M €	+0.5%	1,3 M €	-9.0%	1,4 M €	+2.5%	1,4 M €	-20.5%	1,7 M €	-15.1%	2 M €	+49.8%	1,4 M €	+7.9%	1,3 M €	+18.0%	1,1 M €	-3.5%	1,1 M €	-1.5%	1,1 M €	-5.9%	1,2 M €	-14.6%	1,4 M €	-1.4%	1,4 M €	-7.5%	1,5 M €	-9.5%	1,7 M €	+39.8%	1,2 M €
Cash	188,1 k €	+29.0%	145,8 k €	-25.4%	195,5 k €	+56.4%	125 k €	-70.4%	422,2 k €	+63.1%	258,9 k €	+733%	31,1 k €	-1.4%	31,5 k €	+19.2%	26,4 k €	-9.5%	29,2 k €	-66.5%	87,3 k €	-2.6%	89,6 k €	+15.1%	77,8 k €	+1807%	4,1 k €	-37.2%	6,5 k €	-69.6%	21,4 k €	+196%	7,2 k €
Debts	519 k €	+1.9%	509,1 k €	-21.5%	648,2 k €	+6.3%	610 k €	-36.9%	965,9 k €	-20.2%	1,2 M €	+296%	305,4 k €	-23.8%	401 k €	-1.6%	407,3 k €	-33.1%	609 k €	-18.5%	747,3 k €	-17.2%	902,7 k €	-23.4%	1,2 M €	-2.1%	1,2 M €	-13.0%	1,4 M €	-11.7%	1,6 M €	+42.7%	1,1 M €
Other
Workforce	3,6 ETP	-14.3%	4,2 ETP	0.0%	4,2 ETP	-2.3%	4,3 ETP	+7.5%	4,0 ETP	+29.0%	3,1 ETP	+40.9%	2,2 ETP	+4.8%	2,1 ETP	0.0%	2,1 ETP	-100.0%	84 870,0 ETP	+3857627%	2,2 ETP	0.0%	2,2 ETP	0.0%	2,2 ETP	-26.7%	3,0 ETP	+30.4%	2,3 ETP	0.0%	2,3 ETP	-42.5%	4,0 ETP

Estimate

Indicative valuation

As an indication, this company is worth

between 1 M€ and 2,5 M€

See the valuation

Governance

Board of directors

Seen on filing of 31/12/2025 · 1 active · 2 ended

Active mandates

PHARMACIE LEJEUNE

Director · 0432.865.270

Represented by François-Xavier OLIVIER

Active

Ended mandates

JEAN TRIGAUX

Manager

Ended

PHARMACIE LEJEUNE

Mandate · 0432.865.270

Represented by LUC OLIVIER

Ended

At this address

Other companies at this address

Company	CBE no.
DIAGINVEST● Active	0453.876.460
OLIN-ONE● Active	0724.828.144
PHARMACIE DE DONCEEL● Active	0419.489.069
Pharmacie de la Reffe● Active	0463.249.234
Pharmacie DETRY-DUPONT● Active	0426.774.264
PHARMACIE DUBOIS-DETRY● Active	0812.285.225
PHARMACIE DUBOIS-HUSSON● Active	0422.413.224
PHARMACIE GUSTIN● Active	0870.790.477
PHARMACIE H. DOCK● Active	0477.766.471
PHARMACIE JASSOGNE● Active	0696.591.741
Pharmacie J.P. Detry - Discry● Active	0414.638.871
PHARMACIE KAIRIS● Active	0465.715.707
PHARMACIE LEJEUNE● Active	0432.865.270
PHARMACIE R. WALNIER● Active	0428.635.080
PHARMACIES BIOT-GYSELINCK● Active	0864.202.692
SILVER ONE● Active	0446.907.506

Annual accounts

Full financial information

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	17/06/2026	28/05/2025	25/07/2024	31/07/2023	30/06/2022	30/07/2021
General meeting	18/05/2026	19/05/2025	28/06/2024	30/06/2023	31/05/2022	30/06/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

17 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2025	18/05/2026	17/06/2026	French	PDF
Abridged model	31/12/2024	19/05/2025	28/05/2025	French	PDF
Abridged model	31/12/2023	28/06/2024	25/07/2024	French	PDF
Abridged model	31/12/2022	30/06/2023	31/07/2023	French	PDF
Abridged model	31/12/2021	31/05/2022	30/06/2022	French	PDF
Abridged model	31/12/2020	30/06/2021	30/07/2021	French	PDF
Abridged model	31/12/2019	17/08/2020	10/09/2020	French	PDF
Abridged model	31/12/2018	14/06/2019	22/10/2019	French	PDF
Abridged model	31/12/2017	08/06/2018	24/10/2018	French	PDF
Abridged model	31/12/2016	14/09/2017	29/09/2017	French	PDF
Abridged model	31/12/2015	23/09/2016	15/11/2016	French	PDF
Abridged model	31/12/2014	22/09/2015	29/09/2015	French	PDF
Abridged model	31/12/2013	30/09/2014	25/10/2014	French	PDF
Abridged model	31/12/2012	14/06/2013	24/10/2013	French	PDF
Abridged model	31/12/2011	08/06/2012	03/01/2013	French	PDF
Abridged model	31/12/2010	04/06/2012	08/06/2012	French	PDF
Abridged model	31/12/2009	18/06/2010	25/10/2010	French	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 1 M€ and 2,5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 1 active · 2 ended

Active mandates

PHARMACIE LEJEUNE

Director · 0432.865.270

Represented by François-Xavier OLIVIER

Active

Ended mandates

JEAN TRIGAUX

Manager

Ended

PHARMACIE LEJEUNE

Mandate · 0432.865.270

Represented by LUC OLIVIER

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Mandates24/01/2024
STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - OBJET - DEMISSIONS, NOMINATIONS - ASSEMBLEE GENERALE
PDF
Mandates30/01/2020
MODIFICATION FORME JURIDIQUE - SIEGE SOCIAL - DEMISSIONS, NOMINATIONS
PDF
Registered office10/01/2014
SIEGE SOCIAL
PDF
Other28/10/2008
RUBRIQUE CONSTITUTION (NOUVELLE PERSONNE MORALE, OUVERTURE SUCCURSALE, ETC...)
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2025
Annual accounts 2025166,9 k €↓
2024
Annual accounts 2024192,1 k €↑
2023
Annual accounts 2023183,6 k €↓
2022
Annual accounts 2022191,4 k €↑
2021
Annual accounts 2021172,6 k €↑
2020
Annual accounts 2020169,8 k €↓
2019
Annual accounts 2019195,3 k €↓
2018
Annual accounts 2018199,5 k €↑
2017
Annual accounts 2017162,7 k €↑
2016
Annual accounts 2016121,5 k €↑
2015
Annual accounts 2015111,5 k €↑
2014
Annual accounts 201473,3 k €↑
2013
Annual accounts 201361,9 k €↓
2012
Annual accounts 201264,7 k €↑
2011
Annual accounts 201121,2 k €↑
2010
Annual accounts 201016,5 k €↓
2009
Annual accounts 200920,2 k €
20/10/2008
IncorporationPrivate limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

TRIMEPHAR

Overview

What does TRIMEPHAR do?

Trend over 17 financial years

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline